$9.58
-0.41-4.10%
At close: -
$9.69
0.111.15%
After Hours: 7:10 PM EDT
NeoGenomics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NeoGenomics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-18 | $0.04 | $0.03 | 33.3 % |
Q3 | 2024-11-05 | $0.05 | $0.01 | 400.0 % |
Q2 | 2024-07-29 | $0.03 | $0 | 100.0 % |
Q1 | 2024-04-30 | $-0.02 | $-0.05 | 60.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-18 | $172.00M | $173.40M | -0.81 % |
Q3 | 2024-11-05 | $167.82M | $167.01M | 0.49 % |
Q2 | 2024-07-29 | $164.50M | $161.85M | 1.64 % |
Q1 | 2024-04-30 | $156.24M | $149.89M | 4.24 % |
NeoGenomics (NEO) is scheduled to report earnings on April 29, 2025. The last reported earnings were for reported on February 18, 2025 for Q4.
The Actual EPS was $0.04, which beat the estimate of $0.03.
The Actual Revenue was $172M, which missed the estimate of $173.4M.
Browse earnings estimates, EPS, and revenue on all stocks.